CCAT2 and hepatocellular carcinoma: In HCC, people found that silencing CCAT2 in HCC can down-regulate the expression of vimentin and zinc finger transcription factor Slug (Snail2), and up-regulate the expression of E-cadherin, thereby inhibiting the EMT and metastasis [95].